Table 1:

Baseline and treatment characteristics for 500 patients undergoing ALPPS

Characteristic	Value
Age (y), median (IQR)	61 (52 – 69)
Height (m), median (IQR)	1.7 (1.64 – 1.77)
Weight (kg), median (IQR)	73 (64 – 83)
BMI (kg/m2), median (IQR)	24.8 (22.8 – 27.6)
Standardized pre-stage 1 future liver remnant size, median (IQR)	0.21 (0.16 – 0.26)
Race (%)
White	487 (97.4)
Non-white	13 (2.6)
Tumor type (%)
Colorectal liver metastases	286 (57.2)
Primary liver or biliary tumor	114 (22.8)
Other	100 (20.0)
Diabetes (%)	51 (10.2)
Coronary artery disease (%)	23 (4.6)
Heart failure (%)	12 (2.4)
Peripheral vascular disease (%)	22 (4.4)
Stroke (%)	17 (3.4)
COPD	21 (4.2)
Chronic kidney disease (%)	11 (2.2)
Peptic ulcer disease (%)	23 (4.6)
Surgical approach (%)
Open	466 (93.2)
Laparoscopic	34 (6.8)
Type of ALPPS (%)
Classic	299 (59.8)
Partial/mini	201 (40.2)